'B Me' Unveils Novel Design Concepts Reflecting The Needs Of Individuals With Rheumatoid Arthritis
A unique condom packet. A fashionable wrist splint. Clothing with innovative fasteners. These are just a few examples of design concepts unveiled today as part of the 'B Me' initiative, on display at the annual European League Against Rheumatism (EULAR) congress in Paris.
New Long-Term HUMIRA adalimumab Data Show Up To Seven-Year Efficacy With Combination Treatment For Rheumatoid Arthritis
HUMIRA (adalimumab) resulted in clinical remission among long-standing RA patients when used in combination with methotrexate (MTX). The percentage of patients achieving clinical remission continued to increase after two or more years of continuous treatment with combination therapy.
Multiple Myeloma - Velcade R bortezomib , 30 Complete Response Rate Compared To 4 Percent With Current Drug Treatment Standard Of Care
Abstract Number: 0473 Janssen-Cilag / Ortho Biotech, the biopharmaceutical division of Janssen-Cilag, today announced unprecedented results from a registration-enabling phase III trial evaluating the VELCADE-based therapy with melphalan and prednisone (VMP) compared with melphalan and predni.
Worms By Number - Living Organisms Show An Extraordinary Array Of Patterns
Living organisms show a remarkable range of patterns. Numerical patterns often can be described using mathematical rules and equations. Until now, nature's patterns in some less well-known creatures like marine worms (Polychaeta) have been overlooked.
Death Of Tim Russert - Statement Of The Sudden Cardiac Arrest Assocation
The Sudden Cardiac Arrest Association joins with the many others mourning the death of Tim Russert of NBC News. Our thoughts and prayers are with his family of which he was so proud. Given Mr. Russert's drive for the truth and factual journalism, we encourage the news media to carefully report the facts of his death.
The World's Brain Mapping Experts In Melbourne For Annual Conference
Brain imaging scientists from around the world will attend the 14th Annual Meeting of the Organisation for Human Brain Mapping (OHBM) from 15 - 19 June at the Melbourne Convention Centre.
Poly-MVA - The First Dietary Supplement To Be Cleared By The FDA For Use In A Cancer Study
CancerAssistanceCenter.org announces the immediate availability of free information packets for cancer patients and physicians regarding Poly-MVA, a dietary supplement that has been shown to be very effective in clinical studies conducted by a renowned board-certified oncologist, Dr.
Array BioPharma Presents Additional Positive Phase 1 Results In Two Programs At The 2008 Annual European Congress Of Rheumatology
Array BioPharma Inc. (Nasdaq: ARRY) announced that its Chief Medical Officer, John Yates, M.D., presented additional positive results from a Phase 1 clinical trial evaluating the pharmacokinetic and pharmacodynamic activity of ARRY-162, a novel small molecule MEK inhibitor, at the 2008 Annual European Congress of Rheumatology (EULAR) in Paris, France.
Effects Of Habitat Quality And Size On Extinction In Experimental Populations
In our world of rapidly changing environments, we need to understand how habitat size and quality influence extinction. We examined extinction of experimental Daphnia magna populations in habitats of different size and quality. As expected, we found that extinction was faster in small habitats with less food because these habitats supported smaller populations with lower growth rates.
Science At The Petascale: Mimicking Brain Mechanisms Underlying Human Sight
Less than a week after Los Alamos National Laboratory's Roadrunner supercomputer began operating at world-record petaflop/s data-processing speeds, Los Alamos researchers are already using the computer to mimic extremely complex neurological processes.